BackIntegra Lifesciences Holdings Overview
Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Target Price

Analysts' 12-month price predictions for IART.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.4

Average Target Price

$18.671.4% upside

3 analysts in the last 4 months

High: $25 | Low: $12

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-08BMO Capital$193.3% upsideOpen
2026-06-18Argus Research$2535.9% upsideOpen
2026-04-15Truist FinancialRichard Newitter$1234.8% downsideOpen
2025-10-15Truist Financial$1518.5% downsideOpen
2024-10-07BTIGRyan Zimmerman$208.7% upsideOpen
2024-07-30Truist FinancialRichard Newitter$2641.3% upsideOpen
2024-07-30CitigroupJoanne Wuensch$2325% upsideOpen
2024-07-29BTIGRyan Zimmerman$2219.6% upsideOpen
2024-07-16Truist FinancialRichard Newitter$3273.9% upsideOpen
2024-05-07Truist FinancialRichard Newitter$2535.9% upsideOpen
2024-05-07JMP SecuritiesDavid Turkaly$40117.4% upsideOpen
2024-05-06Wells FargoVik Chopra$2535.9% upsideOpen
2022-10-26Piper SandlerMatt O'Brien$50171.7% upsideOpen
2022-07-28Piper SandlerFY22 EPS$55198.9% upsideOpen
2021-05-20JefferiesAnthony Petrone$86367.4% upsideOpen
2021-04-29RBC CapitalShagun Singh Chadha$74302.2% upsideOpen
2021-04-29Wells FargoLarry Biegelsen$74302.2% upsideOpen